Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years

被引:66
作者
Platteau, P
Staessen, C
Michiels, A
Van Steirteghem, A
Liebaers, I
Devroey, P
机构
[1] Vrije Univ Brussels, Univ Hosp, Ctr Reprod Med, B-1090 Brussels, Belgium
[2] Vrije Univ Brussels, Ctr Med Genet, B-1090 Brussels, Belgium
关键词
advanced reproductive age; chromosomal aneuploidy; FISH; ICSI; IVF; PGD;
D O I
10.1016/j.fertnstert.2005.02.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To provide background information about the average aneuploidy and implantation rates of older patients after IVF with preimplantation genetic diagnosis for aneuploidy screening (PGD-AS) when the patients are subdivided into age categories; and to compare pregnancy outcome data after PGD-AS in this group of patients with a similar control group. Design: Retrospective clinical study. Setting: Patients in an academic reproductive medicine unit. Patient(s): All patients 37 years or older who had PGD-AS between October 1999 and December 2003 and all pregnant patients 37 years or older who IVF/intracytoplasmic sperm injection without PGD-AS during the same period of time. Intervention(s): IVF with PGD-AS. Main Outcome Measure(s): Aneuploidy rate, miscarriage rate, live birth rate, implantation rate, multiple pregnancy rate, and prenatal testing. Result(s): Three hundred ninety-four PGD-AS cycles of patients between 37 and 46 years of age were analyzed. The aneuploidy rate gradually increased with age. The implantation rate remained similar over all age groups. There was a trend to a lower miscarriage and multiple pregnancy rate in the PGD-AS group and a higher delivery/live birth rate. There were five elective terminations of pregnancy after prenatal testing and three late miscarriages due to prenatal testing in the control group. Conclusion(s): Preimplantation genetic diagnosis for aneuploidy screening can give valuable information to older patients concerning the reason why their IVF cycles are unsuccessful and whether it is worthwhile to continue IVF treatment, and it can help patients to avoid the emotional trauma that can occur after prenatal testing during the second trimester of pregnancy.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 36 条
[1]  
[Anonymous], 1977, Human Fertility: The Basic Components
[2]   OPTIMAL PREPARATION OF PREIMPLANTATION EMBRYO INTERPHASE NUCLEI FOR ANALYSIS BY FLUORESCENCE IN-SITU HYBRIDIZATION [J].
COONEN, E ;
DUMOULIN, JCM ;
RAMAEKERS, FCS ;
HOPMAN, AHN .
HUMAN REPRODUCTION, 1994, 9 (03) :533-537
[3]  
*COUNC EUR, 2000, REC DEM DEV EUR
[4]   Aspects of biopsy procedures prior to preimplantation genetic diagnosis [J].
De Vos, A ;
Van Steirteghem, A .
PRENATAL DIAGNOSIS, 2001, 21 (09) :767-780
[5]  
DEMOUZON J, 1993, FERTIL STERIL, V59, P587
[6]   A review of ten years experience of ICSI [J].
Devroey, P ;
Van Steirteghem, A .
HUMAN REPRODUCTION UPDATE, 2004, 10 (01) :19-28
[7]   Comparison of the validity of preimplantation genetic diagnosis for embryo chromosomal anomalies by fluorescence in situ hybridization on one or two blastomeres [J].
Emiliani, S ;
Gonzalez-Merino, E ;
Englert, Y ;
Abramowicz, M .
GENETIC TESTING, 2004, 8 (01) :69-72
[8]   Prognostic role of preimplantation genetic diagnosis for aneuploidy in assisted reproductive technology outcome [J].
Ferraretti, AP ;
Magli, MC ;
Kopcow, L ;
Gianaroli, L .
HUMAN REPRODUCTION, 2004, 19 (03) :694-699
[9]   Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis:: identification of the categories for which it should be proposed [J].
Gianaroli, L ;
Magli, MC ;
Ferraretti, AP ;
Munné, S .
FERTILITY AND STERILITY, 1999, 72 (05) :837-844
[10]   The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy [J].
Gianaroli, L ;
Magli, MC ;
Ferraretti, AP .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 183 :S13-S18